Diversified Energy’s latest sustainability report gives investors a clearer look at how the company manages mature assets, well retirement and regional economic impact...
EDX Medical is supporting a Scottish prostate cancer testing programme for 25,000 men, strengthening its position in early cancer detection and practical diagnostic services...
Arbuthnot Commercial Asset Based Lending is using Growth Guarantee Scheme support to help UK SMEs and mid-market firms access flexible funding for growth, acquisitions and strategic change...
Europe’s strengths in financials, industrials, healthcare and infrastructure could make it a significant beneficiary as AI adoption shifts from builders to enterprise users...
Britain’s electricity market is moving towards cleaner generation, but the biggest investor opportunities may sit in grid access, flexibility, storage and demand management...
Hercules plc highlights practical community delivery through its support for a safer children’s play area and its role in the Octavius Leaving a Legacy collaboration...
MeyGen is moving from proven tidal stream performance towards Phase 2 scale, giving investors a clearer view of tidal power’s role in the future energy mix...
Fibo’s Charteroak case study shows how faster bathroom installation, durable materials and a premium finish can reduce project risk in luxury hospitality refurbishment...
Hardman & Co analyst Mark Thomas discusses NB Private Equity Partners’ latest results, highlighting resilient portfolio earnings growth, a mature exit-ready portfolio and a sizeable buyback commitment. He also explains..
Sterling faces a testing week as UK political risk builds, the dollar gains support from strong jobs data, and risk-sensitive currencies remain under pressure...
Genflow Biosciences is positioning its SIRT6 gene therapy platform within the growing longevity biotech sector, where investors are increasingly focused on clinical evidence and clear development pathways...
Biotech Growth Trust delivered a strong year as its exposure to smaller biotech companies benefited from improved sentiment, a better interest-rate backdrop and rising takeover activity...
Pennon Group reported a statutory pre-tax profit of £114.4 million for the year to 31 March 2026, supported by higher revenues, cost management and the start of its AMP8 investment..
Diversified Energy’s latest sustainability report gives investors a clearer look at how the company manages mature assets, well retirement and regional economic impact...
EDX Medical is supporting a Scottish prostate cancer testing programme for 25,000 men, strengthening its position in early cancer detection and practical diagnostic services...
Arbuthnot Commercial Asset Based Lending is using Growth Guarantee Scheme support to help UK SMEs and mid-market firms access flexible funding for growth, acquisitions and strategic change...
Europe’s strengths in financials, industrials, healthcare and infrastructure could make it a significant beneficiary as AI adoption shifts from builders to enterprise users...
Britain’s electricity market is moving towards cleaner generation, but the biggest investor opportunities may sit in grid access, flexibility, storage and demand management...
Hercules plc highlights practical community delivery through its support for a safer children’s play area and its role in the Octavius Leaving a Legacy collaboration...
MeyGen is moving from proven tidal stream performance towards Phase 2 scale, giving investors a clearer view of tidal power’s role in the future energy mix...
Fibo’s Charteroak case study shows how faster bathroom installation, durable materials and a premium finish can reduce project risk in luxury hospitality refurbishment...
Hardman & Co analyst Mark Thomas discusses NB Private Equity Partners’ latest results, highlighting resilient portfolio earnings growth, a mature exit-ready portfolio and a sizeable buyback commitment. He also explains why dry powder, liquidity pressure and new exit routes could support future realisations, while setting out the risks investors should keep in view...
Sterling faces a testing week as UK political risk builds, the dollar gains support from strong jobs data, and risk-sensitive currencies remain under pressure...
Genflow Biosciences is positioning its SIRT6 gene therapy platform within the growing longevity biotech sector, where investors are increasingly focused on clinical evidence and clear development pathways...
Biotech Growth Trust delivered a strong year as its exposure to smaller biotech companies benefited from improved sentiment, a better interest-rate backdrop and rising takeover activity...
Pennon Group reported a statutory pre-tax profit of £114.4 million for the year to 31 March 2026, supported by higher revenues, cost management and the start of its AMP8 investment programme...
